CYP2C9 Structure−Metabolism Relationships: Substrates, Inhibitors, and Metabolites
- 4 October 2007
- journal article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 50 (22), 5382-5391
- https://doi.org/10.1021/jm070745g
Abstract
The cytochrome P450 (CYP) family is composed of monooxygenases, which mediate the metabolism of xenobiotics and endogenous compounds. The characterization of the interactions between these enzymes and candidate drugs is an important part of the drug discovery process. CYP2C9, one isoform of the CYPs, mediates the oxidation of several important drugs. The aim of this work is to investigate the possibility to study inhibition and substrate interactions with CYP2C9, using docking and the site of metabolism predictions. The model compounds used for the study were the COX-2 inhibitor celecoxib and a series of 13 analogues known to be metabolized by CYP2C9. The results obtained using the two methods gave valuable information about important interactions of inhibitors and substrates with CYP2C9. The two methods could be used to predict the site of metabolism and to determine the productive docking pose for each compound. These predictions were verified by metabolite identification using LC/MS/MS after incubation with recombinant CYP2C9.Keywords
This publication has 21 references indexed in Scilit:
- Computational Models for Predicting Interactions with Cytochrome p450 EnzymeCurrent Topics in Medicinal Chemistry, 2006
- Cytochrome P450 in Silico: An Integrative Modeling ApproachJournal of Medicinal Chemistry, 2005
- STRUCTURAL ANALYSIS OF CYP2C9 AND CYP2C5 AND AN EVALUATION OF COMMONLY USED MOLECULAR MODELING TECHNIQUESDrug Metabolism and Disposition, 2004
- The Structure of Human Cytochrome P450 2C9 Complexed with Flurbiprofen at 2.0-Å ResolutionJournal of Biological Chemistry, 2004
- Crystal structure of human cytochrome P450 2C9 with bound warfarinNature, 2003
- ADMET in silico modelling: towards prediction paradise?Nature Reviews Drug Discovery, 2003
- New methods in predictive metabolismJournal of Computer-Aided Molecular Design, 2002
- Competitive CYP2C9 Inhibitors: Enzyme Inhibition Studies, Protein Homology Modeling, and Three-Dimensional Quantitative Structure-Activity Relationship AnalysisPublished by American Society for Pharmacology & Experimental Therapeutics (ASPET) ,2001
- Mammalian Microsomal Cytochrome P450 Monooxygenase: Structural Adaptations for Membrane Binding and Functional DiversityMolecular Cell, 2000
- Cytochrome P4502C9: an enzyme of major importance in human drug metabolismBritish Journal of Clinical Pharmacology, 1998